Neurocrine Biosciences Inc (NBIX) News
Latest headlines that mention NBIX, newest first · each headline opens the original publisher
- Last price
- $168.42
- Day change
- +2.30%
- Next earnings
- —
NBIX headlines
last 30 daysRecord $1.1B revenue marks transformative quarter for diversified biotech.
Neurocrine's expanding drug portfolio could drive substantial growth through 2031.
NBIX news alerts
Get an alert by email or push when a new headline mentions NBIX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.